---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-120350"
form_type: "8-K"
ticker: null
cik: "0001697532"
company_name: "Applied Therapeutics, Inc."
filed_at: "2022-11-18T23:59:59+00:00"
generated_at: "2026-06-21T15:56:16.870151+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Applied Therapeutics gets Nasdaq deficiency notice as equity falls below $10M minimum

## Summary
- Stockholders' equity was $9.6M as of Sep 30, 2022, below Nasdaq's $10M continued listing requirement.
- Company has until Dec 30, 2022 to submit a compliance plan to regain compliance.
- If plan accepted, Nasdaq may grant until May 14, 2023 to evidence compliance.
- No decisions on response have been made; continued listing not assured.

## SEC filing metadata
- accession: 0001104659-22-120350
- form_type: 8-K
- cik: 0001697532
- company_name: Applied Therapeutics, Inc.
- filed_at: 2022-11-18T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1697532/000110465922120350/0001104659-22-120350-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1697532/000110465922120350/tm2230973d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-120350
- JSON: https://secwatch.observer/filing/0001104659-22-120350.json
- Plain text: https://secwatch.observer/filing/0001104659-22-120350.txt

## Key facts
- Listing & Compliance Notices
  Applied Therapeutics, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5450(b)(1)(A)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: stockholders equity
  - Rules: 5450(b)(1)(A)
  source text: November 15, 2022, Applied Therapeutics, Inc. (the “Company”) received written notification (the “Notice”) from the Nasdaq Stock Market (“Nasdaq”) that, the Company’s stockholders’ equity as reported in its Quarterly Report on Form 10-Q for the period ended September 30, 2022 (the “Form 10-Q”) does not satisfy the continued listing requirement under Nasdaq Listing Rule 5450(b)(1)(A) for the Nasdaq Global Market, which requires that a listed company’s stockholders’ equity be at least $10.0 million (the “Stockholders’ Equity Requirement”). As reported in its Form 10-Q, the Company’s stockholders
  evidence_url: https://www.sec.gov/Archives/edgar/data/1697532/000110465922120350/0001104659-22-120350-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.